Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes
Vincent D Venincasa, Ajay E Kuriyan, Harry W Flynn Jr, Jayanth Sridhar, Darlene Miller Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA Purpose: To report the clinical findings, antibiotic sensitivities, and visual outc...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07ba8412d4084b97a1b873f0b3a5f4a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:07ba8412d4084b97a1b873f0b3a5f4a0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:07ba8412d4084b97a1b873f0b3a5f4a02021-12-02T03:01:42ZEndophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes1177-5483https://doaj.org/article/07ba8412d4084b97a1b873f0b3a5f4a02015-07-01T00:00:00Zhttp://www.dovepress.com/endophthalmitis-caused-by-pantoea-agglomerans-clinical-features-antibi-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Vincent D Venincasa, Ajay E Kuriyan, Harry W Flynn Jr, Jayanth Sridhar, Darlene Miller Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA Purpose: To report the clinical findings, antibiotic sensitivities, and visual outcomes associated with endophthalmitis caused by Pantoea agglomerans.Methods: A consecutive case series of patients with vitreous culture-positive endophthalmitis caused by P. agglomerans from January 1, 1990 to December 31, 2012 at a large university referral center. Findings from the current study were compared to prior published studies.Results: Of the three study patients that were identified, clinical settings included trauma (n=2) and post-cataract surgery (n=1). Presenting visual acuity was hand motion or worse in all three cases. All isolates were sensitive to ceftazidime, gentamicin, imipenem, and fluoroquinolones. All isolates were resistant to ampicillin. Initial treatment strategies were vitreous tap and intravitreal antibiotic injection (n=1) and pars plana vitrectomy with intravitreal antibiotic injection (n=2). At last follow-up, one patient had no light perception vision, while the other two had best-corrected visual acuity of 20/200 and 20/400.Conclusion: All Pantoea isolates were sensitive to ceftazidime, gentamicin, imipenem, and fluoroquinolones. All patients in the current study received at least one intravitreal antibiotic to which P. agglomerans was shown to be sensitive in vitro. In spite of this, the visual outcomes were generally poor.Keywords: ocular infection, trauma, antibiotic resistanceVenincasa VDKuriyan AEFlynn Jr HWSridhar JMiller DDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 1203-1207 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ophthalmology RE1-994 |
spellingShingle |
Ophthalmology RE1-994 Venincasa VD Kuriyan AE Flynn Jr HW Sridhar J Miller D Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes |
description |
Vincent D Venincasa, Ajay E Kuriyan, Harry W Flynn Jr, Jayanth Sridhar, Darlene Miller Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA Purpose: To report the clinical findings, antibiotic sensitivities, and visual outcomes associated with endophthalmitis caused by Pantoea agglomerans.Methods: A consecutive case series of patients with vitreous culture-positive endophthalmitis caused by P. agglomerans from January 1, 1990 to December 31, 2012 at a large university referral center. Findings from the current study were compared to prior published studies.Results: Of the three study patients that were identified, clinical settings included trauma (n=2) and post-cataract surgery (n=1). Presenting visual acuity was hand motion or worse in all three cases. All isolates were sensitive to ceftazidime, gentamicin, imipenem, and fluoroquinolones. All isolates were resistant to ampicillin. Initial treatment strategies were vitreous tap and intravitreal antibiotic injection (n=1) and pars plana vitrectomy with intravitreal antibiotic injection (n=2). At last follow-up, one patient had no light perception vision, while the other two had best-corrected visual acuity of 20/200 and 20/400.Conclusion: All Pantoea isolates were sensitive to ceftazidime, gentamicin, imipenem, and fluoroquinolones. All patients in the current study received at least one intravitreal antibiotic to which P. agglomerans was shown to be sensitive in vitro. In spite of this, the visual outcomes were generally poor.Keywords: ocular infection, trauma, antibiotic resistance |
format |
article |
author |
Venincasa VD Kuriyan AE Flynn Jr HW Sridhar J Miller D |
author_facet |
Venincasa VD Kuriyan AE Flynn Jr HW Sridhar J Miller D |
author_sort |
Venincasa VD |
title |
Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes |
title_short |
Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes |
title_full |
Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes |
title_fullStr |
Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes |
title_full_unstemmed |
Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes |
title_sort |
endophthalmitis caused by pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/07ba8412d4084b97a1b873f0b3a5f4a0 |
work_keys_str_mv |
AT venincasavd endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes AT kuriyanae endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes AT flynnjrhw endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes AT sridharj endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes AT millerd endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes |
_version_ |
1718401961004367872 |